Artwork

Content provided by Jennie Wetter. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jennie Wetter or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Propaganda That Threatens the FDA’s Mifepristone Regulations

38:48
 
Share
 

Manage episode 486649302 series 2581616
Content provided by Jennie Wetter. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jennie Wetter or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Mifepristone is the first (and extremely safe) in two medications that people will take during a medication abortion—and access to it is under blatant attack in the courts. Dr. Ushma Upadhyay, Public Health Scientist based at University of California San Francisco, and Julia Kaye, Senior Staff Attorney with the ACLU’s Reproductive Freedom Project, sit down to talk with us about recent anti-abortion propaganda and how it could be used to shape the FDA’s regulations of medication abortion.

A past case, Alliance for Hippocratic Medicine v. FDA, was brought by anti-abortion groups to a federal judge in Texas known to have a hostile record against abortion with the goal of challenging the FDA’s mifepristone regulations. The Supreme Court ruled that these groups could not challenge the regulations in June 2024. Anti-abortion Attorneys General of Missouri, Kansas, and Idaho are now attempting to revive this litigation, called Missouri v. FDA. Meanwhile, a new report from a Project 2025-backed organization falsely states that 11% of people who have a medication abortion have a serious adverse event. Sec. Kennedy has cited this report as a basis for conducting a “complete review” of the FDA’s mifepristone regulations.

For more information, check out Boom! Lawyered: https://rewirenewsgroup.com/boom-lawyered/

Support the show

Follow Us on Social:
Twitter: @rePROsFightBack
Instagram: @reprosfb
Facebook: rePROs Fight Back
Bluesky: @reprosfightback.bsky.social
Email us: [email protected]
Rate and Review on Apple Podcast
Thanks for listening & keep fighting back!

  continue reading

268 episodes

Artwork
iconShare
 
Manage episode 486649302 series 2581616
Content provided by Jennie Wetter. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jennie Wetter or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Mifepristone is the first (and extremely safe) in two medications that people will take during a medication abortion—and access to it is under blatant attack in the courts. Dr. Ushma Upadhyay, Public Health Scientist based at University of California San Francisco, and Julia Kaye, Senior Staff Attorney with the ACLU’s Reproductive Freedom Project, sit down to talk with us about recent anti-abortion propaganda and how it could be used to shape the FDA’s regulations of medication abortion.

A past case, Alliance for Hippocratic Medicine v. FDA, was brought by anti-abortion groups to a federal judge in Texas known to have a hostile record against abortion with the goal of challenging the FDA’s mifepristone regulations. The Supreme Court ruled that these groups could not challenge the regulations in June 2024. Anti-abortion Attorneys General of Missouri, Kansas, and Idaho are now attempting to revive this litigation, called Missouri v. FDA. Meanwhile, a new report from a Project 2025-backed organization falsely states that 11% of people who have a medication abortion have a serious adverse event. Sec. Kennedy has cited this report as a basis for conducting a “complete review” of the FDA’s mifepristone regulations.

For more information, check out Boom! Lawyered: https://rewirenewsgroup.com/boom-lawyered/

Support the show

Follow Us on Social:
Twitter: @rePROsFightBack
Instagram: @reprosfb
Facebook: rePROs Fight Back
Bluesky: @reprosfightback.bsky.social
Email us: [email protected]
Rate and Review on Apple Podcast
Thanks for listening & keep fighting back!

  continue reading

268 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play